WESCAP Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
WESCAP Management Group's PFE Position: Q1 2026 in Review
WESCAP Management Group sold out of Pfizer (PFE) in Q1 2026, closing a stake of 11,306 shares — an estimated $282K sold.
WESCAP Management Group first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $2.43M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- WESCAP Management Group reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- WESCAP Management Group sold 11,306 Pfizer shares in Q1 2026, an estimated $282K.
- WESCAP Management Group first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
- WESCAP Management Group's Pfizer position peaked at $2.43M in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on WESCAP Management Group's 13F filing for Q1 2026, filed 12 May 2026.